Heart disease is once again the leading cause of death in the U.S., according to a new statistical report from the American ...

Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

A study that reviews the sodium and nutritional content of foods promoted during timeouts and halftime found that adults may ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Ozempic, the diabetes medication popularly used as an “off-label” weight-loss drug, has helped thousands shed excess pounds.

A surge in the flow of aid into the Gaza Strip since the truce between Israel and Hamas took effect on Jan. 19 is likely to ...

The study offers promising news for people with type 2 diabetes. By using SGLT2 inhibitors, they may be able to lower their ...

After learning you have prediabetes, you may work with your healthcare team to make changes to your eating style, weight ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...